An observational study in Bladder Cancer, sponsored by University of California, Davis. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-03-13.
Sponsored by University of California, Davis · Observational
The purpose of this pilot study is to develop the methodology for an innovative subsurface imaging technology that was designed at Lawrence Livermore National Laboratory. It will allow the non-invasive analysis and imaging of tissues and chemical distributions in the body at an imaging depth of up to 1 centimeter with spatial resolution on the order of 1 mm.
This is a pilot, feasibility study to determine if the subsurface imaging technology warrants advancement to a larger clinical trial.
1,616 studies on the registry are indexed under Urinary Bladder Neoplasms; 421 are open to participants now.
This study's enrollment of 26 is below the median of 180 across 374 observational studies indexed under Urinary Bladder Neoplasms.
Browse Urinary Bladder Neoplasms studies →University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.
Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients already scheduled to undergo a bladder surgery at UCDMC.
Exclusion Criteria:
Patients undergoing a surgical bladder procedure in the main O.R.
Accuracy of the subsurface laser to determine cancer cells versus normal cells when viewed endoscopically during a surgical procedure.
Does the subsurface laser allow enough light to visually assess the cells. Logical metric of either "Yes" or "No".
Time frame: 1 year
No study locations are listed for this record.
This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis